New #JITC article: Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial bit.ly/3O8bS1F@andreashr@GroupKyte
Funn fra ALICE-studien publisert i Nature Medicine. Gratulerer så mye @AmundJon og hele resten av teamet! Les mer om studien: matrix-fkb.no/aktuelt/data-f…
We are delighted to share that the first results from the ALICE-trial were today published in Nature Medicine and presented at San Antonio Breast Cancer Symposium. Thanks to the patients and the study teams. Look forward to further work.
rdcu.be/c1geA